HealthTronics buys Endocare for $16mm
Executive Summary
HealthTronics (products and services for urology conditions) has acquired all of the outstanding shares of publicly traded Endocare (ablation technology for prostate tumors). The deal is valued at about $16mm; for every share held, Endocare shareholders have the option to receive $1.35 in cash (not to exceed 50% of the total consideration) or 0.7764 HealthTronics share (but not beyond 75% of the total consideration). The cash-per-share price represents a 118% premium to Endocare's stock average for the 10 days before the company announced in a 424B filing in April that it was considering a written proposal by HealthTronics.
Deal Industry
- Medical Devices
-
Medical Devices
-
Surgical Equipment & Devices
- Minimally or Less Invasive
-
Surgical Equipment & Devices
Deal Status
- Final
Deal Type
-
Acquisition
- Full Acquisition
- Includes Contract
- Payment Includes Cash for Equity
- Payment Includes Stock
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice